Neurocrine Biosciences, Inc. today announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an ...
The potential sale comes after Motley Fool launched a flurry of subsidiaries over the past decade.
U.S. growth stocks and small cap names are faring the worst in early trading, while the S&P 500 is facing its sharpest ...
Trump on Wednesday slapped a 10% baseline tariff on all imports to the United States along with heavy levies on tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback